Tag #Glp-1 Receptor

Showing 1 to 1 of 1 results

elmundo.es
🌐 85% Global Worthiness
News related image

Oral Medication Shows Significant Weight Loss in Obesity Treatment

A phase 3 clinical trial involving 3,100 obese individuals across nine countries demonstrated that orforglipron, a novel oral medication targeting the GLP-1 receptor, resulted in an average 11.2% weight loss, primarily fat mass, and improved cardiovascular risk factors.

Progress

44% Bias Score

Good Health and Well-being

Showing 1 to 1 of 1 results